Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for spinal applications.

Chisa Hidaka1, Safdar N Khan, James C Farmer

  • 1Hospital for Special Surgery, Belfer Gene Therapy Core Facility, Weill Medical College of Cornell University, New York, NY, USA. hidakac@hss.edu

The Orthopedic Clinics of North America
|October 23, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regional and socioeconomic differences in unicompartmental knee arthroplasty utilization: Which patient populations are receiving care?

Journal of orthopaedics·2026
Same author

Modified Integrated Health State Suggests Lower Cumulative Neck Pain-Related Disability After Cervical Disk Replacement Compared With Anterior Cervical Diskectomy and Fusion.

Neurosurgery·2026
Same author

Utilization of robotic pars repair for early return to activity in adolescents with symptomatic spondylolysis: a case series.

Journal of neurosurgery. Spine·2026
Same author

Thoracolumbar Spine Trauma Outcomes: Effect of Ankylosing Spondylitis and Diffuse Idiopathic Skeletal Hyperostosis.

The Journal of the American Academy of Orthopaedic Surgeons·2025
Same author

Recovery Trajectories After Anterior Cervical Discectomy and Fusion.

Spine·2025
Same author

The Role of Enabling Technologies in the Surgical Management of Cervical Spine Deformity.

Clinical spine surgery·2025

Gene therapy offers a promising approach for spinal disorders, enhancing growth factor delivery for fusion, disc regeneration, and injury healing. Adenovirus vectors are widely used for transient, localized growth factor production, with ongoing advancements in vector technology and gene selection.

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Gene Therapy

Background:

  • Gene therapy is a promising drug delivery mechanism for treating spinal disorders, particularly for enhancing growth factor therapy.
  • Current applications focus on spinal fusion, intervertebral disc regeneration, and spinal cord injury healing.
  • Gene therapy enables high-level local production of growth factors, overcoming limitations of short half-lives and the need for external delivery systems.

Purpose of the Study:

  • To review the current state and future potential of gene therapy in treating spinal disorders.
  • To highlight the advantages of gene therapy, such as localized growth factor production and transient expression.
  • To discuss the evolution of gene therapy vectors and candidate genes for spinal applications.

Main Methods:

Related Experiment Videos

  • Adenovirus (Ad) vectors are commonly used for in vivo gene delivery due to their expression profile.
  • Cell-based ex vivo approaches are widely employed for spinal fusion and intervertebral disc regeneration due to tissue density.
  • Advancements include developing less immunogenic viral vectors (AAV, lentivirus) and regulated gene expression systems.

Main Results:

  • Adenovirus vectors provide ideal transient, high-level expression for growth factor therapy in spinal applications.
  • Ex vivo cell-based gene transfer facilitates treatment for dense bone and intervertebral disc tissues.
  • Emerging technologies are identifying new candidate genes and refining vectors for improved efficacy and safety.

Conclusions:

  • Gene therapy, particularly with Adenovirus vectors, is a powerful tool for spinal disorder treatment, offering localized and transient growth factor delivery.
  • Cell-based gene therapy approaches are crucial for dense spinal tissues, while ongoing vector and gene advancements promise more sophisticated future treatments.
  • Future gene therapy strategies may involve multiple, physiologically regulated genes delivered via improved vectors to enhance spinal fusion, disc repair, and spinal cord healing.